摘要
目的:探讨保妇康栓联合普罗雌烯阴道胶丸治疗绝经后人乳头瘤病毒(HPV)感染疗效。方法:2016年1月—2018年1月本院收治的绝经后HPV感染者98例,随机分为治疗组和对照组各49例。对照组给予保妇康栓治疗,治疗组在对照组治疗基础上加普罗雌烯胶囊治疗,评价保妇康栓联合普罗雌烯阴道胶丸治疗HPV感染的临床疗效以及降炎症因子效果。结果:治疗3个月后,两组HPV转阴、临床疗效以及炎症因子均得到改善,但治疗组HPV转阴及部分转阴率(91.8%)、临床总有效率(89.8%)均高于对照组(65.3%、67.3%)(P<0.05),炎症因子水平低于对照组(P<0.05)。结论:保妇康栓联合普罗雌烯阴道胶丸对绝经后HPV病毒感染者清除和临床症状恢复疗效更优。
Objective:To study the therapeutic effect of Baofukang suppository combined with progestil capsule for treating postmenopausal women with human papillomavirus(HPV)infection.Methods:From January 2016 to January 2018,98 postmenopausal women with HPV infection were selected and were randomly divided into the study group and control group(49 cases in each group).The women in the study groups were treated by Baofukang suppository combined with progestil capsule,and the women in the control group were treated by Baofukang suppository.The clinical efficacy and levels of inflammatory factors of women in both groups were evaluated.Results:3 months after treatment,rate of negative HPV,clinical efficacy and inflammatory factors of all women had improved,and the rate of negative HPV and total clinical efficacy rate of women in the study group were 91.8%and 89.8%,which were significant higher than those(65.3%and 67.3%)of women in the control group(P<0.05),and the levels of inflammatory factors of women in the study group were significant lower than those of women in the control group(P<0.05).Conclusion:Baofukang suppository combined with prostaglandin capsule for treating postmenopausal women with HPV can help clearance of HPV,can alleviate the clinical symptoms,and can increase clinical effectiveness.
作者
刘华
朱冬菊
LIU Hua;ZHU Dongju(Beijing Longfu Hospital,Beijing,100010)
出处
《中国计划生育学杂志》
2019年第8期1099-1101,共3页
Chinese Journal of Family Planning